To the Editor : We read with int t terest the paper on 'The incidence of lung cancer in the Gulf Cooperation Council countries" by AltHamdan et al. 1 We are particularly concerned about the number of Bahraini pat t tients with lung cancer included in this paper from the Gulf Centre for Cancer Registration. As such, we wish to provide a short critique of the paper and contribute additional data from Bahrain.
Applying the same WHO crit t teria as those used by AltHamdan, we reviewed all the histopathology and hematopathology archives from all government and private hospit t tals and clinics in Bahrain between 1952 and 2004. During these 52 years, there were 7336 Bahraini patients with malignant neoplat t sia, 3972 males and 3364 females (Table 1) . There were 541 (7.4%) patients with primary lung cancer; 427 (79%) male, 114 (21%) females and sex ratio of 3.7:1. Primary lung cancer ranked 2nd and 11th most common cancer in the males and fet t males respectively. It also accounted for 10.8% and 3.4% of all maligt t nancies in the males and females respectively. Breast cancer was the most common primary malignancy in the general and female cancer population.
In Second, in view of the sampling ambiguities any interpretation of data related to Bahrain would send the wrong messages about the fret t quency, rank, ASR, gender distrit t bution, sex ratio, and histological pattern of cancer patients in general and those of lung in particular. We We feel the 10.4 and 2.6 ASR reported in this communicat t tion for males and females respect t tively, are more realistic and repret t sentative of the incidence of lung cancer in Bahrain. They are also consistent with data from other Gulf states.
4t6 (b) There is no adequate ext t planation for the higher rates of lung cancer in Bahrain in AltHamdan as compared to those of the nearby Arabian Gulf countries, which share many common family, get t netic, environmental and socioecot t nomic factors. Smoking cannot be the sole factor. Otherwise, it would mean that one in every 5 persons in Bahrain will develop lung cancer during their lifetime. Furthermore, while we do not doubt the associat t tion of smoking and lung cancer, we note that all support data used in the AltHamdan et al paper are indirect and refer to the prevalence of smokt t ing in the Arabian Gulf countries. It would have been more meaningt t ful if the authors obtained direct information about smoking among lung cancer patients themselves and correlated this with the anatomical distribution and the histology of the tumours. These gaps imply that the returned cancer notification forms for cancer registration were primarily deficient in fundamental data. (c) The frequency of breast 2, 4, 6 There are 11 names on the aut t thorship list of AltHamdan et al paper of whom at least 6 are regt t istrars of their local cancer regist t tries.
1 This raises an ethical issue of authorship. Thus while we stress that the validity of published data of any cancer registry is determined by the amount of histopathology confirmation of the cases, we note that in AltHamdan study, the eft t fort of the entire behind the scene workforce including histopatholot t gists, who contributed significantly towards its publication, was ignored and not even acknowledged. The international standard of biomedit t cal journals is clearly against this form of authorship unless "contribt t utorship" is acknowledged. 7, 8 We need to stress that the possession of data contributed by others and the administrative affiliation of the "contributorship" are not criteria for authorship.
